Stay updated on Adagrasib Combo in KRAS G12C Clinical Trial

Sign up to get notified when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adagrasib Combo in KRAS G12C Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The site revision has been updated to v3.6.4, replacing v3.6.3, indicating a backend/UI update without changing the study details presented on the page.
    Difference
    0.0%
    Check dated 2026-07-21T12:43:21.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added Fundacao Pio XII - Hospital de Barretos (Barretos, Brazil) with Josiane Mourao Dias at site 007-457 and phone +55 1733 216600; added Universitatsklinikum Augsburg with Bjorn Hackanson at site 007-2222 and phone +498214002729; added Local Institution 007-743-Ph3; updated Primary Completion date to 2028-10-31 and Study Completion date to 2029-10-31 with a Completed status. Removed prior site records and contacts for Xinjiang Medical University Cancer Hospital - Urumqi, Site 007-457, Site 007-2222, and associated not-yet-recruiting/contacts.
    Difference
    0.1%
    Check dated 2026-07-14T09:35:18.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page's revision tag was bumped from v3.6.2 to v3.6.3, indicating a small update to the page's content or metadata.
    Difference
    0.0%
    Check dated 2026-07-07T06:23:59.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.6.0 to v3.6.2, indicating a newer build of the page; this is an internal update with no explicit user-facing content changes.
    Difference
    0.0%
    Check dated 2026-06-27T22:53:12.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The study record has been expanded with numerous new global locations and investigators, increasing the reach to 770 locations and updating site details and contacts. At the same time, several existing site entries and contacts were removed or changed, reflecting a cleanup or reorganization of local institutions.
    Difference
    0.3%
    Check dated 2026-06-19T17:26:39.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    New recruitment locations and site contacts have been added (e.g., Teresa Garcia Manrique in Seville; Saitama Medical University International Medical Center; Gleneagles Penang), expanding the study's recruitment footprint. The total number of locations is updated to 767.
    Difference
    0.2%
    Check dated 2026-05-26T14:45:29.000Z thumbnail image

Stay in the know with updates to Adagrasib Combo in KRAS G12C Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.